GPT and myeloid sarcoma: The present study showed that the prevalence of NAFLD having elevation of ALT was progressively greater in subjects with Non-MS, Pre-MS, and MS, however, independent predictors for NAFLD having elevation of ALT differed among subjects with MS, Pre-MS, and Non-MS.